Hallmark (2022): polymorphic microbiomes
The bacteria living in and around us differ from person to person and influence cancer risk, progression, and how well treatments work.
Gut microbiota modulate immunotherapy response; intratumoural bacteria drive inflammation and chemoresistance; colibactin leaves mutational signatures. FMT and defined consortia are in trials.
Pages like this
not linked directly; found by shared links- TermHallmark (2022): senescent cells
Shares Hallmarks of Cancer 2022: adding phenotypic plasticity, epigenetic reprogramming, microbiomes and senescent cells, Hallmarks of Cancer and the tag hallmark.
- TermHallmark (2022): non-mutational epigenetic reprogramming
Shares Hallmarks of Cancer 2022: adding phenotypic plasticity, epigenetic reprogramming, microbiomes and senescent cells, Hallmarks of Cancer and the tag hallmark.
- TermEnabling characteristic: tumour-promoting inflammation
Shares Hallmarks of Cancer, Microbiome–tumour interactions and the tag hallmark.
- TermHallmark (2022): unlocking phenotypic plasticity
Shares Hallmarks of Cancer 2022: adding phenotypic plasticity, epigenetic reprogramming, microbiomes and senescent cells, Hallmarks of Cancer and the tag hallmark.
- TermHallmark: enabling replicative immortality
Shares Hallmarks of Cancer and the tag hallmark.
- TermHallmark: resisting cell death
Shares Hallmarks of Cancer and the tag hallmark.
- TermHallmark: inducing or accessing vasculature
Shares Hallmarks of Cancer and the tag hallmark.
- TermHallmark: reprogramming cellular metabolism
Shares Hallmarks of Cancer and the tag hallmark.